Oculomic stratification of COVID-19 patients' intensive therapy unit admission status and mortality by retinal morphological findings.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
12 Sep 2024
Historique:
received: 03 12 2023
accepted: 24 07 2024
medline: 13 9 2024
pubmed: 13 9 2024
entrez: 12 9 2024
Statut: epublish

Résumé

To investigate if retinal thickness has predictive utility in COVID-19 outcomes by evaluating the statistical association between retinal thickness using OCT and of COVID-19-related mortality. Secondary outcomes included associations between retinal thickness and length of stay (LoS) in hospital. In this retrospective cohort study, OCT scans from 230 COVID-19 patients admitted to the Intensive Care Unit (ITU) were compared with age and gender-matched patients with pneumonia from before March 2020. Total retinal, GCL + IPL, and RNFL thicknesses were recorded, and analysed with systemic measures collected at the time of admission and mortality outcomes, using linear regression models, Pearson's R correlation, and Principal Component Analysis. Retinal thickness was significantly associated with all-time mortality on follow up in the COVID-19 group (p = 0.015), but not 28-day mortality (p = 0.151). Retinal and GCL + IPL layer thicknesses were both significantly associated with LoS in hospital for COVID-19 patients (p = 0.006 for both), but not for patients with pneumonia (p = 0.706 and 0.989 respectively). RNFL thickness was not associated with LoS in either group (COVID-19 p = 0.097, pneumonia p = 0.692). Retinal thickness associated with LoS in hospital and long-term mortality in COVID-19 patients, suggesting that retinal structure could be a surrogate marker for frailty and predictor of disease severity in this group of patients, but not in patients with pneumonia from other causes.

Identifiants

pubmed: 39266635
doi: 10.1038/s41598-024-68543-z
pii: 10.1038/s41598-024-68543-z
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

21312

Informations de copyright

© 2024. Crown.

Références

World Health Organisation. Weekly epidemiological update on COVID-19. https://www.who.int/publications/m/item/weekly-epidemiological-update-on-covid-19---21-september-2021 (2020).
Zaim, S., Chong, J. H., Sankaranarayanan, V. & Harky, A. Covid-19 and Multiorgan Response. Curr. Probl. Cardiol. https://doi.org/10.1016/j.cpcardiol.2020.100618 (2020).
doi: 10.1016/j.cpcardiol.2020.100618 pubmed: 32439197 pmcid: 7187881
Sim, R. et al. Retinal microvascular signs in COVID-19. Br. J. Ophthalmol. 106, 1308–1312 (2021).
doi: 10.1136/bjophthalmol-2020-318236 pubmed: 33741583
Tang, Y. et al. Cytokine storm in COVID-19: The current evidence and treatment strategies. Front. Immunol. 11, 1708 (2020).
doi: 10.3389/fimmu.2020.01708 pubmed: 32754163 pmcid: 7365923
Rovas, A. et al. Microvascular dysfunction in COVID-19: The MYSTIC study. Angiogenesis 24, 145 (2021).
doi: 10.1007/s10456-020-09753-7 pubmed: 33058027
Courtie, E., Veenith, T., Logan, A., Denniston, A. K. & Blanch, R. J. Retinal blood flow in critical illness and systemic disease: A review. Ann. Intensive Care 10, 1–18 (2020).
doi: 10.1186/s13613-020-00768-3
Cheung, C. Y. et al. Retinal imaging in Alzheimer’s disease. J. Neurol. Neurosurg. Psychiatry https://doi.org/10.1136/jnnp-2020-325347 (2021).
doi: 10.1136/jnnp-2020-325347 pubmed: 34764151
Courtie, E. F. et al. Stability of OCT and OCTA in the intensive therapy unit setting. Diagnostics 11, 1516 (2021).
doi: 10.3390/diagnostics11081516 pubmed: 34441449 pmcid: 8394026
Cheung, C. Y., Wong, T. Y., Ikram, M. K. & Chen, C. P. L. H. Retinal pathology as biomarker for cognitive impairment and Alzheimer’s disease. J. Neurol. Neurosurg. Psychiatry 83, 917–922 (2012).
doi: 10.1136/jnnp-2011-301628 pubmed: 22733082
Lad, E. M. et al. Evaluation of inner retinal layers as biomarkers in mild cognitive impairment to moderate Alzheimer’s disease. PLoS One 13, e0192646 (2018).
doi: 10.1371/journal.pone.0192646 pubmed: 29420642 pmcid: 5805310
Querques, G. et al. Functional and morphological changes of the retinal vessels in Alzheimer’s disease and mild cognitive impairment. Sci. Rep. 9, 63 (2019).
doi: 10.1038/s41598-018-37271-6 pubmed: 30635610 pmcid: 6329813
Patton, N. et al. Retinal vascular image analysis as a potential screening tool for cerebrovascular disease: A rationale based on homology between cerebral and retinal microvasculatures. J. Anat. 206, 319–348 (2005).
doi: 10.1111/j.1469-7580.2005.00395.x pubmed: 15817102 pmcid: 1571489
Courtie, E., Gilani, A., Veenith, T. & Blanch, R. J. Optical coherence tomography angiography as a surrogate marker for end-organ resuscitation in sepsis: A review. Front. Med. https://doi.org/10.3389/fmed.2022.1023062 (2022).
doi: 10.3389/fmed.2022.1023062
Marinho, P. M., Marcos, A. A. A., Romano, A. C., Nascimento, H. & Belfort, R. Retinal findings in patients with COVID-19. Lancet 395, 2020 (2020).
doi: 10.1016/S0140-6736(20)31014-X
Vavvas, D. G., Sarraf, D., Sadda, S. R., Eliott, D. & Ehlers, J. P. Concerns about the interpretation of OCT and fundus findings in COVID-19 patients in recent Lancet publication. Eye https://doi.org/10.1038/s41433-020-1084-9 (2020).
doi: 10.1038/s41433-020-1084-9 pubmed: 32647303
Wagner, S. K. et al. Insights into systemic disease through retinal imaging-based oculomics. Transl. Vis. Sci. Technol. 9, 6–6 (2020).
doi: 10.1167/tvst.9.2.6 pubmed: 32704412 pmcid: 7343674
Stone, K., Zwiggelaar, R., Jones, P. & Mac Parthaláin, N. A systematic review of the prediction of hospital length of stay: Towards a unified framework. PLOS Digit. Health 1, e0000017 (2022).
doi: 10.1371/journal.pdig.0000017 pubmed: 36812502 pmcid: 9931263
Mayer, M. OCTSEG (Optical Coherence Tomography Segmentation and Evaluation GUI). ( https://www.mathworks.com/matlabcentral/fileexchange/66873-octseg-optical-coherence-tomography-segmentation-andevaluation-gui ) (MATLAB Central File Exchange, 2024).
R Core Team. R: A Language and Environment for Statistical Computing. (2023).
Luben, R. et al. Retinal fractal dimension in prevalent dementia: The AlzEye Study. IOVS 63, 4440 (2022).
Wagner, S. K. et al. Association between retinal features from multimodal imaging and schizophrenia. JAMA Psychiatry https://doi.org/10.1001/JAMAPSYCHIATRY.2023.0171 (2023).
doi: 10.1001/JAMAPSYCHIATRY.2023.0171 pubmed: 36947045 pmcid: 10034669
Schurz, N. et al. Evaluation of retinal layer thickness parameters as biomarkers in a real-world multiple sclerosis cohort. Eye Brain 13, 59–69 (2021).
doi: 10.2147/EB.S295610 pubmed: 33737853 pmcid: 7966301
Martinez-Lapiscina, E. H. et al. Retinal thickness measured with optical coherence tomography and risk of disability worsening in multiple sclerosis: A cohort study. Lancet Neurol. 15, 574–584 (2016).
doi: 10.1016/S1474-4422(16)00068-5 pubmed: 27011339
Morley, J. E. et al. Frailty consensus: A call to action. J. Am. Med. Dir. Assoc. 14, 392–397 (2013).
doi: 10.1016/j.jamda.2013.03.022 pubmed: 23764209 pmcid: 4084863
Zhang, X. M. et al. Frailty as a predictor of mortality among patients with COVID-19: A systematic review and meta-analysis. BMC Geriatr. 21, 1–11 (2021).
Sablerolles, R. S. G. et al. Association between Clinical Frailty Scale score and hospital mortality in adult patients with COVID-19 (COMET): An international, multicentre, retrospective, observational cohort study. Lancet Health Longev. 2, e163–e170 (2021).
doi: 10.1016/S2666-7568(21)00006-4
Iwai-Saito, K., Shobugawa, Y., Aida, J. & Kondo, K. Frailty is associated with susceptibility and severity of pneumonia in older adults (A JAGES multilevel cross-sectional study). Sci. Rep. 11, 1–10 (2021).
doi: 10.1038/s41598-021-86854-3
Jiang, R. et al. Associations of physical frailty with health outcomes and brain structure in 483 033 middle-aged and older adults: A population-based study from the UK Biobank. Lancet Digit. Health 5, e350–e359 (2023).
doi: 10.1016/S2589-7500(23)00043-2 pubmed: 37061351 pmcid: 10257912
Hepschke, J. L. et al. Modifications in macular perfusion and neuronal loss after acute traumatic brain injury. Investig. Ophthalmol. Vis. Sci. 64, 1–9 (2023).
SCIE. Social Care Institute for Excellence. https://www.scie.org.uk/care-providers/coronavirus-covid-19/commissioning/hospital-discharge-admissions (2022).
Farrah, T. E. et al. Choroidal and retinal thinning in chronic kidney disease independently associate with eGFR decline and are modifiable with treatment. Nat. Commun. 14, 1–13 (2023).
doi: 10.1038/s41467-023-43125-1
Paterson, E. N. et al. Association of reduced inner retinal thicknesses with chronic kidney disease. BMC Nephrol. 21, 37 (2020).
doi: 10.1186/s12882-019-1679-1 pubmed: 32005180 pmcid: 6995224

Auteurs

Ella Courtie (E)

Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK.
Department of Ophthalmology, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust, West Midlands, UK.
Surgical Reconstruction and Microbiology Research Centre, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.

Matthew Taylor (M)

University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
University of Birmingham, Birmingham, UK.
Birmingham Women's and Children's NHS Foundation Trust, Birmingham, UK.

Dominic Danks (D)

University of Birmingham, Birmingham, UK.
Alan Turing Institute, The British Library, London, UK.

Animesh Acharjee (A)

Institute of Cancer and Genomic Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, B15 2TT, UK.
Institute of Translational Medicine, University Hospitals Birmingham NHS Foundation Trust, Birmingham, B15 2TT, UK.
MRC Health Data Research UK (HDR) Midlands, Birmingham, UK.
Centre for Health Data Research, University of Birmingham, Birmingham, B15 2TT, UK.

Thomas Jackson (T)

Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK.

Ann Logan (A)

Axolotl Consulting Ltd., Worcestershire, Droitwich, UK.
Division of Biomedical Sciences, Warwick Medical School, University of Warwick, Coventry, UK.

Tonny Veenith (T)

Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK.
Critical Care Unit, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
Department of Trauma Sciences, University of Birmingham, Birmingham, UK.

Richard J Blanch (RJ)

Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK. r.j.blanch@bham.ac.uk.
Department of Ophthalmology, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust, West Midlands, UK. r.j.blanch@bham.ac.uk.
Surgical Reconstruction and Microbiology Research Centre, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK. r.j.blanch@bham.ac.uk.
Academic Department of Military Surgery and Trauma, Royal Centre for Defence Medicine, Birmingham, UK. r.j.blanch@bham.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH